RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
0.72%
↑ 104% vs avg
Percentile
P50
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-17.26%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.72% |
| Q2 2025 | -2.70% |
| Q1 2025 | 93.01% |
| Q4 2024 | -140.73% |
| Q3 2024 | 33.43% |
| Q2 2024 | 9.93% |
| Q1 2024 | 1.77% |
| Q4 2023 | 1.64% |
| Q3 2023 | -24.00% |
| Q2 2023 | 13.74% |
| Q1 2023 | -18.90% |
| Q4 2022 | -2.01% |
| Q3 2022 | -2.33% |
| Q2 2022 | 10.99% |
| Q1 2022 | -14.03% |
| Q4 2021 | 4.02% |
| Q3 2021 | -0.46% |
| Q2 2021 | 5.29% |
| Q1 2021 | -28.30% |
| Q4 2020 | 13.43% |
| Q3 2020 | -17.57% |
| Q2 2020 | 9.87% |
| Q1 2020 | 3.67% |
| Q4 2019 | -28.36% |
| Q3 2019 | 8.53% |
| Q2 2019 | -15.65% |
| Q1 2019 | -539.67% |
| Q4 2018 | 8.47% |
| Q3 2018 | 80.87% |
| Q2 2018 | 0.33% |
| Q1 2018 | 0.00% |